1. Home
  2. IMRN vs FTFT Comparison

IMRN vs FTFT Comparison

Compare IMRN & FTFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMRN
  • FTFT
  • Stock Information
  • Founded
  • IMRN 1994
  • FTFT N/A
  • Country
  • IMRN Australia
  • FTFT United States
  • Employees
  • IMRN N/A
  • FTFT N/A
  • Industry
  • IMRN Biotechnology: Pharmaceutical Preparations
  • FTFT Business Services
  • Sector
  • IMRN Health Care
  • FTFT Consumer Discretionary
  • Exchange
  • IMRN Nasdaq
  • FTFT Nasdaq
  • Market Cap
  • IMRN 9.2M
  • FTFT 11.0M
  • IPO Year
  • IMRN N/A
  • FTFT N/A
  • Fundamental
  • Price
  • IMRN $1.80
  • FTFT $2.04
  • Analyst Decision
  • IMRN Strong Buy
  • FTFT
  • Analyst Count
  • IMRN 1
  • FTFT 0
  • Target Price
  • IMRN $5.00
  • FTFT N/A
  • AVG Volume (30 Days)
  • IMRN 46.0K
  • FTFT 403.7K
  • Earning Date
  • IMRN 08-29-2025
  • FTFT 08-19-2025
  • Dividend Yield
  • IMRN N/A
  • FTFT N/A
  • EPS Growth
  • IMRN N/A
  • FTFT N/A
  • EPS
  • IMRN N/A
  • FTFT N/A
  • Revenue
  • IMRN $4,777,422.00
  • FTFT $2,368,206.00
  • Revenue This Year
  • IMRN N/A
  • FTFT N/A
  • Revenue Next Year
  • IMRN N/A
  • FTFT N/A
  • P/E Ratio
  • IMRN N/A
  • FTFT N/A
  • Revenue Growth
  • IMRN 48.63
  • FTFT N/A
  • 52 Week Low
  • IMRN $1.50
  • FTFT $1.01
  • 52 Week High
  • IMRN $2.87
  • FTFT $5.70
  • Technical
  • Relative Strength Index (RSI)
  • IMRN 48.13
  • FTFT 45.44
  • Support Level
  • IMRN $1.80
  • FTFT $1.82
  • Resistance Level
  • IMRN $1.94
  • FTFT $3.88
  • Average True Range (ATR)
  • IMRN 0.08
  • FTFT 0.44
  • MACD
  • IMRN -0.01
  • FTFT -0.04
  • Stochastic Oscillator
  • IMRN 22.22
  • FTFT 10.68

About IMRN Immuron Limited

Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.

About FTFT Future FinTech Group Inc.

Future FinTech Group Inc is engaged in the financial technology business. The company participates in supply chain financing services and trading in China, asset management business in Hong Kong, and cross-border money transfer services in the United Kingdom. It has also expanded into brokerage and investment banking business in Hong Kong and a cryptocurrency mining farm in the U.S. The company's reportable segments include asset management services, supply chain financing and trading, and others.

Share on Social Networks: